Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis.

amyotrophic lateral sclerosis (ALS) disease progression motor neuron disease (MND) motor phenotype site of onset somatotopic organization of motor system

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
03 10 2023
Historique:
received: 20 09 2022
revised: 01 03 2023
accepted: 01 04 2023
medline: 4 10 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

Increasing evidence shows that disease spreading in amyotrophic lateral sclerosis (ALS) follows a preferential pattern with more frequent involvement of contiguous regions from the site of symptom onset. The aim of our study was to assess if: (i) the burden of upper (UMN) and lower motor neuron (LMN) involvement influences directionality of disease spreading; (ii) specific patterns of disease progression are associated with motor and neuropsychological features of different ALS subtypes (classic, bulbar, primary lateral sclerosis, UMN-predominant, progressive muscular atrophy, flail arm, flail leg); and (iii) specific clinical features may help identify ALS subtypes, which remain localized to the site of onset for a prolonged time (regionally entrenching ALS). A single-centre, retrospective cohort of 913 Italian ALS patients was evaluated to assess correlations between directionality of the disease process after symptom onset and motor/neuropsychological phenotype. All patients underwent an extensive evaluation including the following clinical scales: Penn Upper Motor Neuron Score (PUMNS), MRC Scale for Muscle Strength and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). The most frequent initial spreading pattern was that towards adjacent horizontal regions (77.3%), which occurred preferentially in patients with lower MRC scores (P = 0.038), while vertical diffusion (21.1%) was associated with higher PUMNS (P < 0.001) and with reduced survival (P < 0.001). Non-contiguous disease spreading was associated with more severe UMN impairment (P = 0.003), while contiguous disease pattern with lower MRC scores. Furthermore, non-contiguous disease spreading was associated with more severe cognitive impairment in both executive and visuospatial ECAS domains. Individuals with regionally entrenching ALS were more frequently female (45.6% versus 36.9%; P = 0.028) and had higher frequencies of symmetric disease onset (40.3% versus 19.7%; P < 0.001) and bulbar phenotype (38.5% versus 16.4%; P < 0.001). Our study suggests that motor phenotypes characterized by a predominant UMN involvement are associated with a vertical pattern of disease progression reflecting ipsilateral spreading within the motor cortex, while those with predominant LMN involvement display more frequently a horizontal spreading from one side of the spinal cord to the other. These observations raise the hypothesis that one of the mechanisms underlying disease spreading in ALS pathology is represented by diffusion of toxic factors in the neuron microenvironment. Finally, it is possible that in our cohort, regionally entrenching ALS forms are mainly observed in patients with atypical bulbar phenotypes, characterized by a slowly progressive course and relatively benign prognosis.

Identifiants

pubmed: 37075222
pii: 7131295
doi: 10.1093/brain/awad129
pmc: PMC10545526
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4105-4116

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Muscle Nerve. 2008 Mar;37(3):364-75
pubmed: 18080998
Lancet. 2017 Nov 4;390(10107):2084-2098
pubmed: 28552366
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):
pubmed: 28003278
Exp Neurol. 2004 Feb;185(2):232-40
pubmed: 14736504
Brain. 1991 Apr;114 ( Pt 2):843-53
pubmed: 2043953
Ann Clin Transl Neurol. 2020 Jul;7(7):1181-1192
pubmed: 32558369
Neuromuscul Disord. 2001 May;11(4):414-6
pubmed: 11369195
J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):740-6
pubmed: 21402743
Front Neurol. 2022 May 18;13:872500
pubmed: 35665030
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):611-9
pubmed: 26283685
Eur J Neurol. 2022 May;29(5):1402-1409
pubmed: 34989063
Brain. 2022 Nov 21;145(11):3727-3729
pubmed: 36029046
Arch Ital Biol. 2017 Dec 1;155(4):118-130
pubmed: 29405032
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174
pubmed: 28054827
Ann Neurol. 2013 Jul;74(1):20-38
pubmed: 23686809
Muscle Nerve. 1993 Aug;16(8):864-9
pubmed: 8332139
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):85-91
pubmed: 24027298
Neurology. 2006 Jan 24;66(2):265-7
pubmed: 16434671
Annu Rev Neurosci. 2010;33:409-40
pubmed: 20367447
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):489-498
pubmed: 27219526
Brain. 2011 Sep;134(Pt 9):2642-55
pubmed: 21798965
Neurology. 2009 Sep 8;73(10):805-11
pubmed: 19738176
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):339-46
pubmed: 19922121
Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):184-90
pubmed: 26700804
Muscle Nerve. 1995 Mar;18(3):314-8
pubmed: 7870109
J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):917-924
pubmed: 28710326
Brain. 2017 Nov 1;140(11):3055-3061
pubmed: 29088352
Lancet. 2016 Aug 27;388(10047):919-31
pubmed: 26987909
J Clin Med. 2020 Aug 06;9(8):
pubmed: 32781557
Muscle Nerve. 2020 Apr;61(4):508-511
pubmed: 31743477
Neurology. 2007 May 8;68(19):1576-82
pubmed: 17485644
Amyotroph Lateral Scler. 2011 Jul;12(4):283-9
pubmed: 21702735
Neurol Sci. 2007 Apr;28(2):80-6
pubmed: 17464470
Muscle Nerve. 2014 Mar;49(3):439-41
pubmed: 24464677
Chin Med J (Engl). 2017 Aug 5;130(15):1768-1772
pubmed: 28748847
Annu Rev Neurosci. 2008;31:195-218
pubmed: 18558853
Lancet Neurol. 2018 May;17(5):423-433
pubmed: 29598923
Muscle Nerve. 2014 Apr;49(4):469-77
pubmed: 24273101

Auteurs

Alessio Maranzano (A)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.

Federico Verde (F)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.
Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, 20122, Italy.

Eleonora Colombo (E)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.

Barbara Poletti (B)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.

Alberto Doretti (A)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.

Ruggero Bonetti (R)

Neurology Residency Program, Università degli Studi di Milano, Milan, 20122, Italy.

Delia Gagliardi (D)

Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, 20122, Italy.
Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy.

Megi Meneri (M)

Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, 20122, Italy.
Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy.

Luca Maderna (L)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.

Stefano Messina (S)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.

Stefania Corti (S)

Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, 20122, Italy.
Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy.

Claudia Morelli (C)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.

Vincenzo Silani (V)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.
Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, 20122, Italy.

Nicola Ticozzi (N)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, 20149, Italy.
Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, 20122, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH